Forschungsprojekte
Ergebnisse pro Seite:
100
2022 - 2025
Type-I Interferons – a double-edged sword in myeloproliferative neoplasms and chronic viral infections (SFB 1292, TP21)- Prof. Dr. MarkusRadsak,
- Dr. SabineMuth
2022 - 2026
Exploring KrasG12V-specific TCR-like CAR redirected T cells for immunotherapy in non-small cell lung cancer (NSCLC)- PD Dr. UdoHartwig
2021 - 2025
Tumorspezifische Immunisierung durch transkutane Impfung: Präklinische und klinische Entwicklung von Arzneiformen zur adjuvanten Therapie des Mantelzell-Karzinoms (SFB 1066/3, TP B18)- Prof. Dr. MarkusRadsak,
- Prof. Dr. PeterLangguth,
- Univ.-Prof. Dr. StephanGrabbe
2021 - 2040
Therapie der Myelofibrose mit KRT-232 in Kombination mit Ruxolitinib (#1262)- Prof. Dr. MarkusRadsak
2021 - 2024
Targeting chromatin complexes to reverse AML immune escape for engineered cell therapy (SFB 1292, TP 12)- Dr. MichaelKühn,
- Prof. Dr. EvelynUllrich
2021 - 2023
Utilization of the HLA-independent anti-tumor T-cell repertoire for cancer immunotherapy- Univ.-Prof. Dr. ThomasWölfel
2021 - 2023
Development and characterization of a mouse model of immuno-aging- Prof. Dr. WolframRuf,
- Dr. MichaelKühn,
- Dr. BorhaneGuezguez,
- Dr. SebastianKreiter
2020 - 2022
Understanding the mechanism of action of p53-isoforms as a potential molecular modulators of T-cell effector function- Dr. HakimEchchannaoui,
- Univ.-Prof. Dr. MatthiasTheobald
2020 - 2021
Exploring NKp44-CAR redirected T cells for adoptive immunotherapy- JuliaOberbauer,
- PD Dr. Udo F.Hartwig
2020 - 2023
Mechanistic and functional dissection of early resistance to epigenetic inhibitors in Acute Myeloid Leukemia- Dr. DanielSasca
2019 - 2023
Clinical Development of imiquimod based immunotherapy (TRR156, KS01)- Prof. Dr. MarkusRadsak
2019 - 2022
End of Life Care in the setting of a nursing home - a retrospective data analysis based on the nursing care records- Univ.-Prof. Dr. MartinWeber
2019 - 2021
Stromal profiling of bone marrow micro-environment in clonal hematopoiesis and myelodysplasia- Dr. BorhaneGuezguez
2019 - 2040
A Phase I/II clinical trial for TCR modified T cells MDG1011in HR myeloid and lymphatic neoplasms (#799)- Dr. Eva MariaWagner-Drouet
2019 - 2040
V114 in recipients of allogeneic hematopoietic stem cell transplant (#796)- Dr. DanielTeschner
2019 - 2020
Thrombosis and inflammation in patients with paroxysmal nocturnal hemoglobinuria (PNH) - A role for neutrophil activation- Prof. Dr. MarkusRadsak
2019 - 2021
T-cell-receptor redirected CD3+ natural killer cells for adoptive immunotherapy to acute myeloid leukemia- JanWernersbach,
- Dr. Udo F.Hartwig
2019 - 2021
Clinical development of lead neoantigen-specific T-cell receptors for adoptive T-cell therapy- Univ.-Prof. Dr. ThomasWölfel
2019 - 2021
NK-Zell-Subpopulationen in der Prognose von Glioblastomen- Dr. Eva MariaWagner-Drouet,
- Dr. MirjamRenovanz
2019 - 2040
MPNSG (BiO)-Project in BCR-ABL1-negative Myeloid Neoplasms (#1141)- Prof. Dr. MarkusRadsak